[
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1 shows the baseline and follow-up fundus photographs of eyes that had incident MMD over the follow-up period.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was seen.Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Enlargement of the PPA was observed.Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\nFundus photographs of eyes showing MMD progression with changes in plus lesions over a 6-year period. (A) Fundus photographs from a 50-year-old Chinese man showing progression of MMD (widening of existing lacquer cracks) over a follow-up of 6 years. (A1) Image from the right eye obtained at baseline visit (SE of –14.0 D and AL of 30.0 mm) showing linear lacquer cracks across the macula (white arrows). (A2) Six years later, widening of existing lacquer cracks temporal to the macula was seen (black arrows). (B) Fundus photographs from a 47-year-old woman showing progression of MMD (enlargement of diffuse chorioretinal atrophy and new lacquer crack) over a follow-up of 6 years. (B1) Image from the right eye obtained at baseline visit (SE of –9.0 D and AL of 29.1 mm) showing slight peripapillary diffuse chorioretinal atrophy (white arrowheads). (B2) Six years later, enlargement of diffuse chorioretinal atrophy (black arrowheads) toward the macula and development of lacquer cracks (red arrows) superior and temporal to the macula were observed.The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In the 49 eyes with MMD progression (Table 4), six (12.2%) had progression from Meta-PM category 2 to 3 with the development of new patchy chorioretinal atrophy (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Of 288 eyes with preexisting MMD, 33 eyes (11.5%) had enlargement of existing diffuse chorioretinal atrophy (Fig. 3A), five (1.7%) had enlargement of existing patchy chorioretinal atrophy (Fig. 3B), and two (0.7%) had enlargement of both existing diffuse and patchy chorioretinal atrophy (Fig. 3C) over the 6-year follow-up.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel B",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "Panel C",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For changes in plus lesions over the 6-year follow-up, four eyes (1.4%) had widening preexisting lacquer cracks and five eyes (1.7%) had development of new lacquer cracks (Fig. 4).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The progression of MMD was higher at 71.4% in eyes with Meta-PM categories 3 or 4 at baseline than those with Meta-PM category 2 at 14.2% (P < 0.001; Fig. 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Of these 24 eyes (Table 7), 6 (25.0%) had an increase in Meta-PM categories, comprising 5 eyes with progression from Meta-PM category 2 to 3 (development of new patchy chorioretinal atrophy) and 1 eye with progression from Meta-PM category 2 to 4 (development of new macular atrophy; Fig. 6A).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Enlargement of existing diffuse, patchy, and macular chorioretinal atrophy over the 6-year follow-up occurred in five (4.6%), nine (8.3%), and four (3.7%) eyes, respectively (Fig. 6B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  }
]